3 completed, 2 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow LuMind IDSC Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LIFE-DSR-Biomarker Sub-study of Biomarkers in Down Syndrome Related Alzheimer's Disease (DS-AD) [18F]MK-6240 - Down Syndrome | Phase 3 | Terminated | LuMind IDSC Foundation | 5 | 2023-06-27 | 2025-03-06 |
| Goal Attainment Scaling (GAS) Sub-Study Alzheimer's Disease in Down Syndrome | Completed | LuMind IDSC Foundation | 46 | 2021-06-30 | 2024-07-03 | |
| Life Skills Improved in Children With Down Syndrome After Using Assistive Technology The MapHabit System - Down Syndrome, Adaptive Behavior | Not applicable | Completed | MapHabit, Inc. | 26 | 2020-09-20 | 2023-02-24 |
| Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome Alzheimer's Disease in Down Syndrome | Terminated | LuMind IDSC Foundation | 252 | 2019-06-30 | 2024-06-27 | |
| Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome ACI-24 low dose, ACI-24 high dose, Placebo - Down Syndrome | Phase 1 | Completed | AC Immune SA | 20 | 2016-03-01 | 2021-10-15 |
Down Syndrome (5) · Alzheimer Disease (2) · Cognitive Dysfunction (1)
United States (5)
Lois Kelly (1) · Michael S. Rafii, MD, PhD (1) · Stuart Zola, PhD (1)
R01AG047922 (1), R43AG065081 (1)